Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Postoperative Fontan Patients
NCT03575572Phase 3Terminated
- Sponsor
- University of Michigan
- Start
- Aug 2018
- Primary completion
- Jan 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of colchicine in single ventricle heart disease (SVD) and pleural effusion, sponsored by University of Michigan. Primary endpoints: Change in Cytokine Total Mass in Pleural Fluid and Difference in Change of Cytokine Concentrations in Pleural Fluid. Started Aug 2018; status: terminated.
02
Drugs
colchicine
03
Conditions
single ventricle heart disease (SVD)pleural effusion
Beyond the preview
Go deeper on NCT03575572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575572.